Reply to Commentary on 'HER2 immunohistochemical and fluorescence in situ hybridization discordances in invasive breast carcinoma with micropapillary features'.

Stewart, Rachel L; Gulbahce, Evin H; Geiersbach, Katherine B; Downs-Kelly, Erinn

Stewart, Rachel L; Gulbahce, Evin H; Geiersbach, Katherine B; Downs-Kelly, Erinn.

Afiliação

Stewart RL; Department of Pathology, ARUP Laboratories, University of Utah Medical Center, University of Utah, Salt Lake City, UT, USA.
Gulbahce EH; Department of Pathology, ARUP Laboratories, University of Utah Medical Center, University of Utah, Salt Lake City, UT, USA.
Geiersbach KB; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
Downs-Kelly E; Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH, USA.

Mod Pathol ; 31(4): 686, 2018 04.

Article em En | MEDLINE | ID: mdl-29666479

Assuntos

Neoplasias da Mama; Hibridização in Situ Fluorescente; Carcinoma Ductal de Mama; Humanos; Imuno-Histoquímica; Hibridização In Situ; Receptor ErbB-2

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Hibridização in Situ Fluorescente Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google